Clinical 0 8 0 8 B-clinical_variable
stage 9 14 9 14 I-clinical_variable
> 15 16 15 16 O
T2b 16 19 16 19 B-lower_bound
or 20 22 20 22 O
evidence 23 31 23 31 O
of 32 34 32 34 O
nodal 35 40 35 40 O

Eastern 0 7 41 48 B-clinical_variable
Cooperative 8 19 49 60 I-clinical_variable
Oncology 20 28 61 69 I-clinical_variable
Group 29 34 70 75 I-clinical_variable
( 35 36 76 77 I-clinical_variable
ECOG 36 40 77 81 I-clinical_variable
) 40 41 81 82 I-clinical_variable
Performance 42 53 83 94 I-clinical_variable
status 54 60 95 101 I-clinical_variable
≤ 61 62 102 103 O
2 63 64 104 105 B-upper_bound

PSA 0 3 106 109 B-clinical_variable
≥ 4 5 110 111 O
15 6 8 112 114 B-lower_bound
ng 9 11 115 117 I-lower_bound
/ 11 12 117 118 I-lower_bound
mL 12 14 118 120 I-lower_bound

Patient 0 7 121 128 O
must 8 12 129 133 O
not 13 16 134 137 O
have 17 21 138 142 O
had 22 25 143 146 O
any 26 29 147 150 O
prior 30 35 151 156 O
treatment 36 45 157 166 O
for 46 49 167 170 O
prostate 50 58 171 179 B-cancer
cancer 59 65 180 186 I-cancer

Patients 0 8 187 195 O
must 9 13 196 200 O
have 14 18 201 205 O
MRI 19 22 206 209 B-treatment
findings 23 31 210 218 O
reporting 32 41 219 228 O
intraprostatic 42 56 229 243 O
lesions 57 64 244 251 O
suspicious 65 75 252 262 O
for 76 79 263 266 O
malignancy 80 90 267 277 B-cancer

Patients 0 8 278 286 O
must 9 13 287 291 O
have 14 18 292 296 O
histopathology 19 33 297 311 B-treatment
confirmed 34 43 312 321 O
prostate 44 52 322 330 B-cancer
cancer 53 59 331 337 I-cancer
that 60 64 338 342 O
is 65 67 343 345 O
Gleason 68 75 346 353 B-clinical_variable
score 76 81 354 359 I-clinical_variable
≤7(4 82 86 360 364 O
+ 86 87 364 365 I-upper_bound
3 87 88 365 366 I-upper_bound
) 88 89 366 367 I-upper_bound
clinical 90 98 368 376 B-clinical_variable
stage 99 104 377 382 I-clinical_variable
≤ 105 106 383 384 O
T2bN0M0 107 114 385 392 B-upper_bound
with 115 119 393 397 O
a 120 121 398 399 O
Prostate 122 130 400 408 B-clinical_variable
- 130 131 408 409 I-clinical_variable
specific 131 139 409 417 I-clinical_variable
antigen 140 147 418 425 I-clinical_variable
( 148 149 426 427 I-clinical_variable
PSA 149 152 427 430 I-clinical_variable
) 152 153 430 431 I-clinical_variable
below 154 159 432 437 O
15 160 162 438 440 B-upper_bound
ng 163 165 441 443 I-upper_bound
/ 165 166 443 444 I-upper_bound
mL 166 168 444 446 I-upper_bound

Patients 0 8 447 455 O
with 9 13 456 460 O
uncontrolled 14 26 461 473 O
intercurrent 27 39 474 486 O
illness 40 47 487 494 O
including 48 57 495 504 O
, 57 58 504 505 O
but 59 62 506 509 O
not 63 66 510 513 O
limited 67 74 514 521 O
to 75 77 522 524 O
ongoing 78 85 525 532 O
or 86 88 533 535 O
active 89 95 536 542 B-chronic_disease
infection 96 105 543 552 I-chronic_disease
, 105 106 552 553 O
symptomatic 107 118 554 565 B-chronic_disease
congestive 119 129 566 576 I-chronic_disease
heart 130 135 577 582 I-chronic_disease
failure 136 143 583 590 I-chronic_disease
, 143 144 590 591 O
unstable 145 153 592 600 B-chronic_disease
angina 154 160 601 607 I-chronic_disease
pectoris 161 169 608 616 I-chronic_disease
, 169 170 616 617 O
cardiac 171 178 618 625 B-chronic_disease
arrhythmia 179 189 626 636 I-chronic_disease
, 189 190 636 637 O
or 191 193 638 640 O
psychiatric 194 205 641 652 B-chronic_disease
illness 206 213 653 660 I-chronic_disease
/ 213 214 660 661 I-chronic_disease
social 214 220 661 667 I-chronic_disease
situations 221 231 668 678 I-chronic_disease
that 232 236 679 683 O
would 237 242 684 689 O
limit 243 248 690 695 O
compliance 249 259 696 706 O
with 260 264 707 711 O
study 265 270 712 717 O
requirements 271 283 718 730 O

Subjects 0 8 731 739 O
must 9 13 740 744 O
have 14 18 745 749 O
an 19 21 750 752 O
International 22 35 753 766 B-clinical_variable
Prostate 36 44 767 775 I-clinical_variable
Symptom 45 52 776 783 I-clinical_variable
Score 53 58 784 789 I-clinical_variable
of 59 61 790 792 O
≤ 62 63 793 794 O
15 64 66 795 797 B-upper_bound

